TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy

Journal of Autoimmunity

Volumn 35, Issue 4, 2010, Pages 291-298

  Summers, S A ^a,b   Hoi, A ^a   Steinmetz, O M ^a   O'Sullivan, K M ^a   Ooi, J D ^a   Odobasic, D ^a   Akira, S ^c   Kitching, A R ^a,b   Holdsworth, S R ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Autoimmunity; Cellular immunity; Glomerulonephritis; Macrophage; TLR

Indexed keywords

AUTOANTIBODY; COMPLEMENT; CYTOKINE; DOUBLE STRANDED DNA ANTIBODY; GAMMA INTERFERON; IMMUNOGLOBULIN; INTERLEUKIN 17 ANTIBODY; INTERLEUKIN 6; PRISTANE; RIBONUCLEOPROTEIN ANTIBODY; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELLULAR IMMUNITY; COMPLEMENT DEPOSITION; CYTOKINE PRODUCTION; DISEASE COURSE; HELPER CELL; HUMORAL IMMUNITY; HYPERGAMMAGLOBULINEMIA; KIDNEY INJURY; LUPUS ERYTHEMATOSUS NEPHRITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROLIFERATIVE GLOMERULONEPHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TH1 CELL; TH17 CELL; WILD TYPE;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; HUMANS; KIDNEY; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; TERPENES; TH1 CELLS; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9;

EID: 77958151575     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2010.05.004     Document Type: Article

References (40)

1. Koffler D., Agnello V., Thoburn R., Kunkel H.G. Systemic lupus erythematosus: prototype of immune complex nephritis in man. The Journal of Experimental Medicine 1971 Sep 1, 134(3 Pt 2):169s-179s.
2. Ward M.M., Pyun E., Studenski S. Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus. Archives of Internal Medicine 1996 Jun 24, 156(12):1337-1344.
3. Wofsy D., Seaman W.E. Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4. The Journal of Experimental Medicine 1985 Feb 1, 161(2):378-391.
4. Wofsy D., Seaman W.E. Reversal of advanced murine lupus in NZB/NZW F1 mice by treatment with monoclonal antibody to L3T4. Journal of Immunology 1987 May 15, 138(10):3247-3253.
5. Alexopoulos E., Seron D., Hartley R.B., Cameron J.S. Lupus nephritis: correlation of interstitial cells with glomerular function. Kidney International 1990 Jan, 37(1):100-109.
6. Satoh M., Richards H.B., Shaheen V.M., Yoshida H., Shaw M., Naim J.O., et al. Widespread susceptibility among inbred mouse strains to the induction of lupus autoantibodies by pristane. Clinical and Experimental Immunology 2000 Aug, 121(2):399-405.
7. Richards H.B., Satoh M., Shaw M., Libert C., Poli V., Reeves W.H. Interleukin 6 dependence of anti-DNA antibody production: evidence for two pathways of autoantibody formation in pristane-induced lupus. The Journal of Experimental Medicine 1998 Sep 7, 188(5):985-990.
8. Richards H.B., Satoh M., Jennette J.C., Okano T., Kanwar Y.S., Reeves W.H. Disparate T cell requirements of two subsets of lupus-specific autoantibodies in pristane-treated mice. Clinical and Experimental Immunology 1999 Mar, 115(3):547-553.
9. Richards H.B., Satoh M., Jennette J.C., Croker B.P., Yoshida H., Reeves W.H. Interferon-gamma is required for lupus nephritis in mice treated with the hydrocarbon oil pristane. Kidney International 2001 Dec, 60(6):2173-2180.
10. Calvani N., Satoh M., Croker B.P., Reeves W.H., Richards H.B. Nephritogenic autoantibodies but absence of nephritis in Il-12p35-deficient mice with pristane-induced lupus. Kidney International 2003 Sep, 64(3):897-905.
11. Papadimitraki E.D., Choulaki C., Koutala E., Bertsias G., Tsatsanis C., Gergianaki I., et al. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process. Arthritis and Rheumatism 2006 Nov, 54(11):3601-3611.
12. Benigni A., Caroli C., Longaretti L., Gagliardini E., Zoja C., Galbusera M., et al. Involvement of renal tubular Toll-like receptor 9 in the development of tubulointerstitial injury in systemic lupus. Arthritis and Rheumatism 2007 May, 56(5):1569-1578.
13. Papadimitraki E.D., Tzardi M., Bertsias G., Sotsiou E., Boumpas D.T. Glomerular expression of toll-like receptor-9 in lupus nephritis but not in normal kidneys: implications for the amplification of the inflammatory response. Lupus 2009 Aug, 18(9):831-835.
14. Christensen S.R., Kashgarian M., Alexopoulou L., Flavell R.A., Akira S., Shlomchik M.J. Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. The Journal of Experimental Medicine 2005 Jul 18, 202(2):321-331.
15. Pawar R.D., Patole P.S., Ellwart A., Lech M., Segerer S., Schlondorff D., et al. Ligands to nucleic acid-specific toll-like receptors and the onset of lupus nephritis. Journal of American Society of Nephrology 2006 Dec, 17(12):3365-3373.
16. Christensen S.R., Shupe J., Nickerson K., Kashgarian M., Flavell R.A., Shlomchik M.J. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 2006 Sep, 25(3):417-428.
17. Hang L., Slack J.H., Amundson C., Izui S., Theofilopoulos A.N., Dixon F.J. Induction of murine autoimmune disease by chronic polyclonal B cell activation. The Journal of Experimental Medicine 1983 Mar 1, 157(3):874-883.
18. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000 Dec 7, 408(6813):740-745.
19. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y., et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. Journal of Immunology 1999 Apr 1, 162(7):3749-3752.
20. Reeves W.H., Lee P.Y., Weinstein J.S., Satoh M., Lu L. Induction of autoimmunity by pristane and other naturally occurring hydrocarbons. Trends in Immunology 2009 Sep, 30(9):455-464.
21. Summers S.A., Steinmetz O.M., Li M., Kausman J.Y., Semple T., Edgtton K.L., et al. Th1 and Th17 cells induce proliferative glomerulonephritis. Journal of American Society of Nephrology 2009 Dec, 20(12):2518-2524.
22. Hoi A.Y., Hickey M.J., Hall P., Yamana J., O'Sullivan K.M., Santos L.L., et al. Macrophage migration inhibitory factor deficiency attenuates macrophage recruitment, glomerulonephritis, and lethality in MRL/lpr mice. Journal of Immunology 2006 Oct 15, 177(8):5687-5696.
23. Santiago-Raber M.L., Baudino L., Izui S. Emerging roles of TLR7 and TLR9 in murine SLE. Journal of Autoimmunity 2009, 33(3-4):231-238.
24. Savarese E., Steinberg C., Pawar R.D., Reindl W., Akira S., Anders H.J., et al. Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis. Arthritis and Rheumatism 2008, 58(4):1107-1115.
25. Santiago-Raber M.L., Dunand-Sauthier I., Wu T., Li Q.Z., Uematsu S., Akira S., et al. Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice. Journal of Autoimmunity 2009 Nov 25.
26. Cella M., Facchetti F., Lanzavecchia A., Colonna M. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nature Immunology 2000 Oct, 1(4):305-310.
27. Lartigue A., Courville P., Auquit I., Francois A., Arnoult C., Tron F., et al. Role of TLR9 in anti-nucleosome and anti-DNA antibody production in lpr mutation-induced murine lupus. Journal of Immunology 2006 Jul 15, 177(2):1349-1354.
28. Thibault D.L., Graham K.L., Lee L.Y., Balboni I., Hertzog P.J., Utz P.J. Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus. Arthritis Research & Therapy 2009, 11(4):R112.
29. Baudino L., Azeredo da Silveira S., Nakata M., Izui S. Molecular and cellular basis for pathogenicity of autoantibodies: lessons from murine monoclonal autoantibodies. Springer Seminars in Immunopathology 2006 Oct, 28(2):175-184.
30. Summers S.A., Steinmetz O.M., Kitching A.R., Holdsworth S.R. Toll like receptor 9 ligation enhances experimental crescentic glomerulonephritis. Journal of American Society of Nephrology Abstracts Issue 2009, 20:2009. TH-PO824.
31. Anders H.J., Banas B., Linde Y., Weller L., Cohen C.D., Kretzler M., et al. Bacterial CpG-DNA aggravates immune complex glomerulonephritis: role of TLR9-mediated expression of chemokines and chemokine receptors. Journal of American Society of Nephrology 2003 Feb, 14(2):317-326.
32. Nadasdy T., Laszik Z., Blick K.E., Johnson L.D., Silva F.G. Proliferative activity of intrinsic cell populations in the normal human kidney. Journal of American Society of Nephrology 1994 Jun, 4(12):2032-2039.
33. Bloch D.B., Rabkina D., Bloch K.D. The cell proliferation-associated protein Ki-67 is a target of autoantibodies in the serum of MRL mice. Laboratory Investigation; A Journal of Technical Methods and Pathology 1995 Sep, 73(3):366-371.
34. Peng S.L., Moslehi J., Craft J. Roles of interferon-gamma and interleukin-4 in murine lupus. The Journal of Clinical Investigation 1997 Apr 15, 99(8):1936-1946.
35. Erb K.J., Ruger B., von Brevern M., Ryffel B., Schimpl A., Rivett K. Constitutive expression of interleukin (IL)-4 in vivo causes autoimmune-type disorders in mice. The Journal of Experimental Medicine 1997 Jan 20, 185(2):329-339.
36. Lattanzio G., Libert C., Aquilina M., Cappelletti M., Ciliberto G., Musiani P., et al. Defective development of pristane-oil-induced plasmacytomas in interleukin-6-deficient BALB/c mice. The American Journal of Pathology 1997 Sep, 151(3):689-696.
37. Calvani N., Caricchio R., Tucci M., Sobel E.S., Silvestris F., Tartaglia P., et al. Induction of apoptosis by the hydrocarbon oil pristane: implications for pristane-induced lupus. Journal of Immunology 2005 Oct 1, 175(7):4777-4782.
38. Lartigue A., Colliou N., Calbo S., Francois A., Jacquot S., Arnoult C., et al. Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus. Journal of Immunology 2009 Nov 15, 183(10):6207-6216.
39. Zhang Z., Kyttaris V.C., Tsokos G.C. The role of IL-23/IL-17 axis in lupus nephritis. Journal of Immunology 2009 Sep 1, 183(5):3160-3169.
40. Liu B., Yang Y., Dai J., Medzhitov R., Freudenberg M.A., Zhang P.L., et al. TLR4 up-regulation at protein or gene level is pathogenic for lupus-like autoimmune disease. Journal of Immunology 2006 Nov 15, 177(10):6880-6888.